MARATTO

article · Journal of Science and Diseases

Sildenafil and Cerebrovascular Accident in A 33-year-old Man: A Case Report From Buea Regional Hospital, Cameroon

2026Open accessUniversity of Buea

Abstract

Sildenafil increases cerebral blood flow and is even good for patients with ischaemic stroke because it is a vasodilator, but it is bad for people with risk factors for haemorrhagic stroke. A 33-year-old man was admitted in our intensive care unit in a comatose state, following a relapse of brain haemorrhage. The family reported that he was a smoker, alcoholic, and Tramadol consumer. He had had seizures followed by coma with left hemiplegia two weeks before admission in our unit after taking 600mg of sildenafil (Viagra). He was initially hospitalized in a clinic before referral to our unit for better management of severe respiratory distress in coma. A cerebral CT scan revealed intraventricular haemorrhage and cerebral oedema classified Fisher 4. The patient was managed with Nimodipine, oxygen therapy, antibiotics and supportive care. Unfortunately, the family had difficulties in purchasing the required medications and the patient died on the seventh day of hospitalization. Sildenafil in high doses probably induce cerebrovascular accidents that can be fatal, especially if it is associated with alcohol abuse, smoking, and Tramadol. This case highlights the fatal outcome of Sildenafil abuse and serves as a warning to users of unprescribed doses.

Research topics

  • Pharmaceutical Quality and Counterfeiting
  • Sexual function and dysfunction studies
  • Forensic Toxicology and Drug Analysis

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.64294/jsd.v4i2.383

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.